(Q36599035)

15 August 2017

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction (English)

1 reference

acute myocardial infarction

15 August 2017

1 reference

1 reference

7

Ellis CJ

1 reference

15 August 2017

9

White HD

1 reference

15 August 2017

French JK

1

1 reference

15 August 2017

Williams BF

2

1 reference

15 August 2017

Hart HH

3

1 reference

15 August 2017

Wyatt S

4

1 reference

15 August 2017

Poole JE

5

1 reference

15 August 2017

Ingram C

6

1 reference

15 August 2017

Williams MG

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

15 August 2017

5

1 reference

inferred from page(s)

published in

The BMJ

1 reference

15 August 2017

312

1 reference

15 August 2017

7047

1 reference

15 August 2017

1637-1641

1 reference

Implementing findings of research

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Selection of patients with acute myocardial infarction for thrombolytic therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Thrombolytic therapy in acute myocardial infarction following prolonged cardiopulmonary resuscitation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Thrombolysis in patients with diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Thrombolytic therapy in patients requiring cardiopulmonary resuscitation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351378

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

20 September 2018

1 reference

12 December 2020

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

12 December 2020

Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage

1 reference

12 December 2020

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

12 December 2020

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

1 reference

12 December 2020

Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel

1 reference

12 December 2020

Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction

1 reference

12 December 2020

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

1 reference

12 December 2020

Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction

1 reference

12 December 2020

Thrombolysis and acute myocardial infarction

1 reference

12 December 2020

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

12 December 2020

Treating menstruating women with thrombolytic therapy: Insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial

1 reference

12 December 2020

10.1136/BMJ.312.7047.1637

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

8664716

1 reference